S
Sanara MedTech Inc. (SMTI)
NCM – Real vaqt narxi. Valyuta: USD
20.44
+2.42 (13.43%)
Yopilishda: May 12, 2026, 4:00 PM EDT
21.26
+0.82 (4.01%)
Bozor oldidan: May 13, 2026, 4:07 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
20.44
+2.42 (13.43%)
Yopilishda: May 12, 2026, 4:00 PM EDT
21.26
+0.82 (4.01%)
Bozor oldidan: May 13, 2026, 4:07 AM EDT
Sanara MedTech Inc. tibbiy texnologiyalar kompaniyasi bo'lib, Qo'shma Shtatlardagi shifokorlar, kasalxonalar, klinika va post-o'tkir parvarish muassasalari uchun jarrohlik yechimlarini ishlab chiqadi, sotadi va tarqatadi. Kompaniya CellerateRX Surgicalni taklif etadi, bu I turdagi mol kollagenining tibbiy gidrolizati bo'lib, jarrohlik, travmatik, to'liq va qisman qalinlikdagi yaralar, shuningdek, birinchi va ikkinchi darajali kuyishlarni boshqarish uchun ko'rsatilgan. U, shuningdek, yaralarni yuvish uchun ishlatiladigan yuvishsiz jarrohlik yechimi bo'lgan BIASURGE; muzlatilgan, ko'p qatlamli ingichka ichak submukozasining hujayradan tashqari matritsali varag'i bo'lgan FORTIFY Tissue Repair Graft (FORTIFY TRG); suyak o'sishini graft joyiga olib boradigan osteokonduktiv, bioaktiv, g'ovakli implant bo'lgan BiFORM, va uni chiziq sifatida ishlatish yoki suyak nuqsonini to'ldirish uchun xamirga aylantirish mumkin; tabiiy ravishda olingan, differentsiatsiyalangan allograft matritsasi bo'lgan ACTIGEN Inductive Bone Matrix; suyakdan olingan progenitor hujayralari va moslashuvchan suyak tolalarini o'z ichiga olgan inson allograft hujayrali suyak matritsasi bo'lgan ALLOCYTE Plus; va kuchli ishlov berish xususiyatlariga ega anatomik to'siq sifatida ishlatiladigan, xavfsiz o'rnatish uchun tikilishi mumkin bo'lgan ko'p qatlamli amniotik membran allografti bo'lgan TEXAGENni ishlab chiqadi. Kompaniya Rochal bilan BIASURGE Advanced Surgical Solution, BIAKŌS Antimicrobial Wound Gel va inson tanasidagi mikroblarni oldini olish va davolash uchun BIAKŌS Antimicrobial Skin and Wound Cleanserni o'z ichiga olgan antimikrobiyal mahsulotlarni ishlab chiqish, sotish va sotish uchun litsenziya shartnomasiga ega. Sanara MedTech Inc. 2001 yilda tashkil etilgan va Fort Worth, Texasda joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. Bill Fitzgerald | Chief Compliance Officer |
| Mr. Jacob A. Waldrop | Chief Operating Officer |
| Mr. Ronald T. Nixon | Executive Chairman |
| Mr. Seth D. Yon | President, CEO & Director |
| Mr. Tyler Palmer | Chief Corporate Development & Strategy Officer |
| Ms. Ashley M. Mackey | Principal Accounting Officer |
| Ms. Elizabeth B. Taylor | Chief Financial Officer |
| Ms. Nina Bionda | Chief R&D Officer |
| Ms. Tricia Matteson | Vice President of Marketing |
| Suresh V. Muppalla | President & CEO of THP |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-17 | DEFA14A | formdefa14a.htm |
| 2026-03-24 | 8-K | form8-k.htm |
| 2026-03-02 | 8-K | form8-k.htm |
| 2026-01-23 | 8-K | form8-k.htm |
| 2025-11-26 | 8-K | form8-k.htm |
| 2025-11-12 | 8-K | form8-k.htm |
| 2025-11-12 | 10-Q | form10-q.htm |
| 2025-09-02 | 8-K | form8-k.htm |
| 2025-08-13 | 8-K | form8-k.htm |
| 2025-08-13 | 10-Q | form10-q.htm |